Custom Development
Your Partner for Custom Solutions
We partner with publicly and privately funded research organizations—including universities, governmental agencies, and healthcare companies—to develop custom compounded solutions for clinical trials and special projects.
Custom compounds from concept to completion
Initial Consultation
Pine begins by thoroughly understanding your unique needs and project objectives. Our experts then create a comprehensive plan that details the project scope, timeline, and estimated costs.
Collaborative Development
Our Innovation & Development team works hand-in-hand with you to refine the formula and design. We keep you involved at every stage, ensuring the final product meets your precise guidelines.
Quality Assurance
Throughout development, we maintain strict quality control and conduct rigorous testing to maintain the highest levels of quality, safety, and efficacy. Regular updates keep you informed, with opportunities to review and provide feedback.
Final Product & Delivery ️
Once the final formulation is approved, we proceed with production, ensuring the timely delivery of a finished product that ultimately meets the needs of your patients.
Let’s collaborate
We tailor each solution to meet the specific needs of your project and elevate patient care.
We prioritize collaboration and transparency to ensure your project is managed with precision and care every step of the way.
Jim Ando, Pharm.D.
Manager – Innovation & Development
Explore our product portfolio
Our extensive portfolio of ready-to-administer and ready-to-use drug products offers extended dating and non-patient-specific ordering, enabling your practice to always have inventory on hand and ready to go.
Quality
Every product that leaves our FDA-registered facility is manufactured following a strictly controlled process.
Learn more
About Us
Our focus is simple. Delivering affordable, reliable, and high-quality drugs our customers can trust.
Learn more
Facility
Our new 75,000-square-foot facility gives us the agility to address drug supply issues quickly and the flexibility to adapt as needs change.
